FIELD: medicine, oncology. SUBSTANCE: method involves determination quantity of parenchymatous cells, fibroblasts and fibrocytes localized periarterially in histological slices of tumor. Fibroadenoma is diagnosed at amount of indicated above cells 18.67 ± 1.96, 11.91 + 0.81 and 14.00 + 1.07 or above, respectively. Mamma cancer is diagnosed at amount of parenchymatous cells 44.62 + 6.56 or above, fibroblasts - 8.32 + 0.61 or less, and fibrocytes - 8.65 + 0.72 or less. EFFECT: increased precision of diagnosis. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSIS OF FIBROADENOMA AND BREAST CANCER IN HISTOLOGICAL SLICES | 1994 |
|
RU2119668C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF FIBROADENOMA AND BREAST CANCER | 2020 |
|
RU2730993C2 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DETECTING THE CASES OF HYPERPLASTIC PROCESSES AND MAMMARY GLAND CANCER IN HISTOLOGIC SLICES | 1994 |
|
RU2107911C1 |
| METHOD FOR PREDICTING BENIGN MAMMARY PATHOLOGY | 2005 |
|
RU2283491C1 |
| METHOD OF DIAGNOSIS OF NECROSIS IN HISTOLOGICAL SLICES | 1994 |
|
RU2094806C1 |
| METHOD FOR DETECTING PROTEINS ON HISTOLOGIC SECTIONS IN APPLYING METHODS OF IMMUNOCHEMISTRY | 1994 |
|
RU2098825C1 |
| METHOD FOR APPLYING ADJUVANT AND MEDICAMENTOUS MAMMARY GLAND CANCER THERAPY | 1999 |
|
RU2166938C1 |
| METHOD FOR MATCHING THE ACCESS OF OPERATIVE INTERFERENCE AT OVARIAN TUMORS | 2005 |
|
RU2283499C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF INVASIVE DUCTAL CANCER AND MAMMARY GLAND FIBROADENOMA | 2015 |
|
RU2613879C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MAMMARY GLAND CANCER AND CENTRAL BROKEN BREAST | 2007 |
|
RU2336823C1 |
